Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 28, 2014, 07:20:54 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 632131
  • Total Topics: 47863
  • Online Today: 257
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: african hiv vaccine trial  (Read 1899 times)

0 Members and 1 Guest are viewing this topic.

Offline hussy_24

  • Member
  • Posts: 48
african hiv vaccine trial
« on: February 08, 2007, 09:31:39 AM »
http://news.bbc.co.uk/1/hi/health/6342575.stm

Thursday, 8 February 2007, 13:40 GMT 

African HIV vaccine trial launch

The first large-scale trial of an HIV vaccine is set to begin in South Africa, it has been announced.
Three thousand HIV negative men and women who are sexually active will be immunised in the four-year study.

An international team of researchers, led by experts from the US, will oversee the trial of the vaccine, created by the drug company Merck.

It is hoped the study will provide information about how a vaccine will work in a heterosexual population.

It should also show if it is effective among women.

The test vaccine has already been through trials for safety and immune response in the Americas, Africa and Australia.

It does not contain live HIV, so cannot cause infection, but does contain copies of three HIV genes. The hope is that exposure to these genes prompts an immune response in the body so that cells containing HIV virus would be recognised and destroyed.

The study, jointly run by the international HIV Vaccine Trials Network (HVTN) and the South African Aids Vaccine Initiative (SAAVI) is also designed to show if the vaccine, which is based on the B strain of HIV, has the potential to protect against the C strain of the virus, which is the subtype prevalent in South Africa.

'Daily burden'

All those who take part will be aged 18 to 35. No pregnant women will be involved in the trial.

Some will be given the vaccine, while others will be given a dummy version of the jab.

Everyone will receive advice about how to practice safe sex.

The trial has been approved by the South African Medicines Control Council and the South African Department of Agriculture, and has been reviewed by the US Food and Drug Administration.

Even if the trial provides positive findings, there would have to be further studies before the vaccine could be licensed.

Dr Lawrence Corey, the lead researcher for the HVTN who is based at Fred Hutchinson Cancer Research Center in Seattle, who is running the study, said: "This trial will answer several major scientific issues that face all of us in the field of HIV-vaccine development.

"It will determine the usefulness of vaccines that induce high immune response to the parts of the virus that are similar between different strains of HIV."

Dr Glenda Gray, of the Perinatal HIV Research Unit at the University of Witwatersrand in Soweto who is also working on the study, said: "Our communities here in South Africa are faced with the burden of HIV on a daily basis, and the trial investigators and study team have spent years developing a rapport with the community so that together we can move forward in our quest to identify improved approaches to prevent new HIV infections."

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.